Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Razan Zatarah

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|May 20, 2026
Tolerability and safety of extemporaneously prepared oral methotrexate suspension in pediatric acute lymphoblastic leukemia: Experience from a comprehensive cancer center in JordanManar Z Dirani, Mahmoud Rezeq, Batoul Zreigat, et al.
Discover Oncology|October 17, 2022
Validation of the <sup>CSR</sup>FENCE score for prediction of febrile neutropenia during chemotherapy cycles 2-6Razan Zatarah, Nour Faqeer, Aseel Mahmoud, et al.
Cancer Reports (Hoboken, N.J.)|March 11, 2025
Microbiological Profiles and Resistance Patterns in Pediatrics With Cancer: An 8-Year Study at a Comprehensive Cancer Center in JordanDana Hassouneh, Razan Zatarah, Aseel AbuSara, et al.
JNCI Cancer Spectrum|June 11, 2022
Validation of the FENCE Risk Groups for Prediction of Febrile Neutropenia With First-Cycle ChemotherapyRazan Zatarah, Nour Faqeer, Tasnim Quraan, et al.
PLOS Digital Health|June 22, 2023
Bias in artificial intelligence algorithms and recommendations for mitigationLama H Nazer, Razan Zatarah, Shai Waldrip, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|May 20, 2026
Tolerability and safety of extemporaneously prepared oral methotrexate suspension in pediatric acute lymphoblastic leukemia: Experience from a comprehensive cancer center in JordanManar Z Dirani, Mahmoud Rezeq, Batoul Zreigat, et al.
Discover Oncology|October 17, 2022
Validation of the <sup>CSR</sup>FENCE score for prediction of febrile neutropenia during chemotherapy cycles 2-6Razan Zatarah, Nour Faqeer, Aseel Mahmoud, et al.
Cancer Reports (Hoboken, N.J.)|March 11, 2025
Microbiological Profiles and Resistance Patterns in Pediatrics With Cancer: An 8-Year Study at a Comprehensive Cancer Center in JordanDana Hassouneh, Razan Zatarah, Aseel AbuSara, et al.
JNCI Cancer Spectrum|June 11, 2022
Validation of the FENCE Risk Groups for Prediction of Febrile Neutropenia With First-Cycle ChemotherapyRazan Zatarah, Nour Faqeer, Tasnim Quraan, et al.
PLOS Digital Health|June 22, 2023
Bias in artificial intelligence algorithms and recommendations for mitigationLama H Nazer, Razan Zatarah, Shai Waldrip, et al.
Pageof 1